Cargando…

HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus

A novel coronavirus has been identified as an etiological agent of severe acute respiratory syndrome (SARS). To rapidly identify anti-SARS drugs available for clinical use, we screened a set of compounds that included antiviral drugs already in wide use. Here we report that the HIV-1 protease inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamamoto, Norio, Yang, Rongge, Yoshinaka, Yoshiyuki, Amari, Shinji, Nakano, Tatsuya, Cinatl, Jindrich, Rabenau, Holger, Doerr, Hans Wilhelm, Hunsmann, Gerhard, Otaka, Akira, Tamamura, Hirokazu, Fujii, Nobutaka, Yamamoto, Naoki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2004
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111005/ https://www.ncbi.nlm.nih.gov/pubmed/15144898 http://dx.doi.org/10.1016/j.bbrc.2004.04.083

Ejemplares similares

Nelfinavir and Nelfinavir Analogs Block Site-2 Protease Cleavage to Inhibit Castration-Resistant Prostate Cancer
por: Guan, Min, et al.
Publicado: (2015)

The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir
por: Subeha, Mahbuba R., et al.
Publicado: (2020)

New Insights into the In Silico Prediction of HIV Protease Resistance to Nelfinavir
por: Antunes, Dinler A., et al.
Publicado: (2014)

Investigation of the influence of EPs(®) 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses
por: Michaelis, Martin, et al.
Publicado: (2011)

Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activity
por: Koltai, Tomas
Publicado: (2015)

Treatment of SARS with human interferons
por: Cinatl, J, et al.
Publicado: (2003)

Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies
por: Kuate, Seraphin, et al.
Publicado: (2007)

A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors
por: Blumenthal, Gideon M., et al.
Publicado: (2014)

Development of antiviral therapy for severe acute respiratory syndrome
por: Cinatl, Jindrich, et al.
Publicado: (2005)

Efficacy of various disinfectants against SARS coronavirus
por: Rabenau, H.F., et al.
Publicado: (2005)

Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir
por: Grigorian, Aline, et al.
Publicado: (2008)

The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia
por: Meier-Stephenson, Vanessa, et al.
Publicado: (2017)

Exploratory Studies on Development of the Chemokine Receptor CXCR4 Antagonists Toward Downsizing
por: Tamamura, Hirokazu, et al.
Publicado: (2008)

Inhibition of apoptosis prevents West Nile virus induced cell death
por: Kleinschmidt, Malte C, et al.
Publicado: (2007)

Treatment of SARS with human interferons
por: Cinatl, J, et al.
Publicado: (2003)

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus
por: Cinatl, J, et al.
Publicado: (2003)

Induction of Suicidal Erythrocyte Death by Nelfinavir
por: Bissinger, Rosi, et al.
Publicado: (2015)

Nelfinavir Inhibits the TCF11/Nrf1-Mediated Proteasome Recovery Pathway in Multiple Myeloma
por: Fassmannová, Dominika, et al.
Publicado: (2020)

The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma
por: Besse, Lenka, et al.
Publicado: (2023)

Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings
por: Widera, Marek, et al.
Publicado: (2021)

SARS-coronavirus (SARS-CoV) and the safety of a solvent/detergent (S/D) treated immunoglobulin preparation
por: Rabenau, H.F., et al.
Publicado: (2005)

Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2
por: Michaelis, Martin, et al.
Publicado: (2019)

Nelfinavir, an HIV-1 Protease Inhibitor, Induces Oxidative Stress–Mediated, Caspase-Independent Apoptosis in Leishmania Amastigotes
por: Kumar, Pranav, et al.
Publicado: (2010)

Effect of nelfinavir stereoisomers on coronavirus main protease: Molecular docking, molecular dynamics simulation and MM/GBSA study
por: Sargolzaei, Mohsen
Publicado: (2021)

Nelfinavir: An Old Ally in the COVID-19 Fight?
por: Gidari, Anna, et al.
Publicado: (2022)

Glycyrrhizin Exerts Antioxidative Effects in H5N1 Influenza A Virus-Infected Cells and Inhibits Virus Replication and Pro-Inflammatory Gene Expression
por: Michaelis, Martin, et al.
Publicado: (2011)

Stability and inactivation of SARS coronavirus
por: Rabenau, H. F., et al.
Publicado: (2004)

Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir
por: Bolcato, Giovanni, et al.
Publicado: (2020)

HIV protease inhibitor nelfinavir is a potent drug candidate against echinococcosis by targeting Ddi1-like protein
por: Liu, Zhongli, et al.
Publicado: (2022)

Highly potent anti-HIV-1 activity isolated from fermented Polygonum tinctorium Aiton
por: Zhong, Yu, et al.
Publicado: (2005)

Bilateral uveitis associated with concurrent administration of rifabutin and nelfinavir
por: Cheng, Wen-Hsin, et al.
Publicado: (2015)

Identification of Natural Products Inhibiting SARS-CoV-2 by Targeting Viral Proteases: A Combined in Silico and in Vitro Approach
por: Wasilewicz, Andreas, et al.
Publicado: (2023)

ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer
por: Wilson, James M., et al.
Publicado: (2016)

Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma
por: Besse, Lenka, et al.
Publicado: (2021)

1128. Efficacy and Safety of Nelfinavir in Asymptomatic and Mild COVID-19 Patients: A Multicenter, Randomized Controlled Trial
por: Kohno, Shigeru, et al.
Publicado: (2022)

Oncolytic Effects of a Novel Influenza A Virus Expressing Interleukin-15 from the NS Reading Frame
por: van Rikxoort, Marijke, et al.
Publicado: (2012)

Structural studies on molecular mechanisms of Nelfinavir resistance caused by non-active site mutation V77I in HIV-1 protease
por: Gupta, Ankita, et al.
Publicado: (2015)

Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells
por: Brüning, Ansgar, et al.
Publicado: (2010)

Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines
por: Morgenstern, Birgit, et al.
Publicado: (2005)

Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children
por: Resino, Salvador, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_99vovdkg2hrti8fcaba5pt5h5o